Last Week in Medicine Anticoagulation in AF with Cirrhosis, Trends in Anticoagulation for Acute PE, Beta Blockers for Acute MI with Normal EF, Finerenone for HFpEF, Continuous vs Intermittent Infusion for Antibiotics, Cefepime vs Piperacillin-Tazobactam for Sepsis
Sep 23, 2024
Dr. Jenkins, an insightful contributor in internal medicine, dives into groundbreaking studies that could change clinical practice. He discusses the best anticoagulants for patients with cirrhosis and atrial fibrillation, pondering the roles of apixaban and rivaroxaban. The conversation pivots to the efficacy of beta blockers post-myocardial infarction, questioning traditional protocols. They also explore antibiotic delivery methods in sepsis and compare cefepime against piperacillin-tazobactam, raising concerns about efficacy and safety in treatment.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 2min
Family Life and Academic Journeys
02:10 • 5min
Anticoagulant Management in Cirrhosis and Atrial Fibrillation
07:29 • 19min
Reevaluating Post-MI Treatment Protocols
26:26 • 12min
Exploring Antibiotic Infusion Strategies in Sepsis
38:36 • 10min
Insights from the ACORN Trial: Antibiotic Efficacy and Neurological Risks
48:11 • 1min
Navigating Sepsis and Antibiotic Challenges
49:32 • 15min